About Gout, Urate, and Crystal Deposition Disease

Aims

Gout, Urate, and Crystal Deposition Disease (ISSN 2813-4583) is an international, open access journal on gout, urate, and crystal deposition disease. GUCDD publishes reviews, regular research papers (articles) and short communications. Gout and crystal deposition-associated disorders are among the leading causes of inflammation and arthritis throughout the world, with gout being the most common form of inflammatory arthritis affecting adults. Historically referred to as “the disease of kings,” the causes and mechanisms of gout, its comorbidities, and related crystal-deposition diseases have been poorly understood over the centuries. Recently, however, research in this field has markedly expanded. The growth of this work has been in step with the increased prevalence and awareness of inflammatory crystal-associated diseases globally, as well as the recognition that the common disorder hyperuricemia is directly linked with not only gouty arthritis but also implicated in diseases of major organ systems. Concurrently, the field has expanded to include more disciplines, including genomics, nephrology, cardiology, endocrinology, urology, and advanced imaging.

This journal is intended both for researchers and for clinicians who are actively managing patients. Readers and authors will be particularly interested in the epidemiology, pathophysiology, imaging, diagnosis, treatment, and outcomes of gout, hyperuricemia, degenerative and inflammatory calcium crystal arthropathies (including calcium pyrophosphate and basic calcium phosphate crystal deposition disease). In addition, readers and authors will include those interested in crystal deposition disorders that involve not only the joint, but also renal, vascular, and other extra-articular tissues. The journal will publish high quality, basic-translational and clinical-translational studies, including clinical trials. In addition, the G-CAN annual research symposium abstracts and a wide array of reviews and editorials will be published in this journal. The range of investigative work presented in the journal will not only be international, but also both inter- and multi-disciplinary. Major sources of published works will include clinicians such as rheumatologists, nephrologists, cardiologists, endocrinologists and orthopedists, and researchers in epidemiology, genomics, bioinformatics, other data sciences, and advanced imaging.

Scope

Range of investigative work in this journal includes, but is not limited to:

  • Gout
  • Hyperuricemia and Urate Biology
  • Inflammatory Arthritis
  • Degenerative Joint Disease
  • Cartilage Disease
  • Rheumatology and Orthopedics
  • Advanced Imaging
  • Crystallography
  • Clinical Pharmacology
  • Biochemistry
  • Ion Transport
  • Epidemiology
  • Genetics and Genomics
  • Molecular Biology
  • Chronic Kidney Disease
  • Cardiovascular Disease
  • Podiatry and Physical Medicine

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in GUCDD will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

© 2024 by the authors. Published by MDPI on behalf of the Gout, Hyperuricemia and Crystal Associated Disease Network. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Reprints

Reprints may be ordered. Please contact for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is .

Editorial Office

Contact us

For further MDPI contacts, see here.

Back to TopTop